Cargando…
Approval success rates of drug candidates based on target, action, modality, application, and their combinations
The current success rate of a drug candidate, from the beginning of the clinical trial to receiving marketing approval, is about 10%–20%, and it has not changed during the past few decades. Therefore, pharmaceutical companies are under pressure to select one compound, among many others, with a high...
Autores principales: | Yamaguchi, Shingo, Kaneko, Masayuki, Narukawa, Mamoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212735/ https://www.ncbi.nlm.nih.gov/pubmed/33831276 http://dx.doi.org/10.1111/cts.12980 |
Ejemplares similares
-
Response rate of anticancer drugs approved by the Food and Drug Administration based on a single-arm trial
por: Oda, Yoshihiro, et al.
Publicado: (2022) -
A Comparison of Safety Information in Drug Labeling at the Initial Approval of New Drugs Approved Both in Japan and the United States
por: Hoshino, Yuko, et al.
Publicado: (2022) -
Factors associated with successful phase III trials for solid tumors: A systematic review
por: Otsuka, Yasushi, et al.
Publicado: (2021) -
Randomized controlled trial data for successful new drug application for rare diseases in the United States
por: Kubota, Yosuke, et al.
Publicado: (2023) -
Points to consider: efficacy and safety evaluations in the clinical development of ultra-orphan drugs
por: Maeda, Kojiro, et al.
Publicado: (2017)